NOK 2.3
(0.88%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.03 NOK | 94.44% |
2022 | -2.70 NOK | 41.94% |
2021 | -4.65 NOK | 21.45% |
2020 | -5.92 NOK | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.03 NOK | 0.0% |
2024 Q2 | - NOK | 0.0% |
2023 Q1 | -0.11 NOK | 0.0% |
2023 FY | - NOK | 94.44% |
2023 Q2 | -0.11 NOK | 0.0% |
2022 FY | - NOK | 41.94% |
2021 FY | - NOK | 21.45% |
2020 FY | - NOK | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Arctic Bioscience AS | -1.79 NOK | 98.223% |
Aqua Bio Technology ASA | -0.99 NOK | 96.788% |
ArcticZymes Technologies ASA | 0.38 NOK | 108.368% |
BerGenBio ASA | -13.30 NOK | 99.761% |
Hofseth BioCare ASA | -0.27 NOK | 88.222% |
PCI Biotech Holding ASA | -0.54 NOK | 94.111% |
Ultimovacs ASA | -5.50 NOK | 99.422% |